Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Evanova
- Development stage
- Unknown
- Lead developer
- Charak
- Administration
- Oral
01
Overview
Evanova is a proprietary Ayurvedic formulation developed by Charak Pharma for the management of perimenopausal, menopausal, and postmenopausal symptoms. It is a non-hormonal, plant-based therapy enriched with phytoestrogens (primarily from soya isoflavones), adaptogens, and mineral bhasmas. Evanova helps alleviate vasomotor symptoms such as hot flashes and night sweats, while also addressing psychological symptoms like irritability, insomnia, mood swings, and fatigue. Additionally, it provides nutritional support to help prevent postmenopausal complications such as osteoporosis and cardiovascular disorders.
- Brand names
- Evanova
- Other names
- Evanova Capsule
Beyond the preview
Go deeper on Evanova.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Evanova.